Medicine

Integrating liver endpoints in clinical tests of cardiovascular as well as renal disease

.Nature Medication, Published online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Perspective calls for inclusion of people along with MASLD and also dimension of liver outcomes in cardio-- renal-- metabolic trials, when records advise mechanistically probable benefits and scientific safety and security-- and also describes points to consider for trial layout and also regulative commendation.